ArticleMethodsX2026
Validation of intensive care unit predictive scoring systems in West Africans.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intensive care unit(ICU) predictive scoring systems (PSS) are valuable in predicting outcomes in the ICU. However, they have not been validated in many populations, including West Africans, limiting their utility in these populations. The study population comprises Ghanaians managed in the ICUs of two major tertiary/quaternary hospitals in Ghana from 2017 to 2026. The Acute Physiologic and Chronic Health Evaluation-IV(APACHE-IV), Simplified Acute Physiologic Score-III (SAPS-III), Mortality Prediction Model-III(MPM0-III), Sequential (Sepsis-related) Organ Failure Assessment(SOFA)/quick SOFA(qSOFA), and National Early Warning Score-2(NEWS-2) scores will be calculated. For APACHE-IV, SAPS-III, and MPM0-III, the primary outcome measures are mortality and/or length of stay(LOS). The APACHE IV, SAPS-III, and MPM0-III scores and their corresponding predicted mortality ratios will be calculated. The overall observed and predicted ICU mortality rates will be assessed. Validation will be tested by assessing calibration and discrimination. For SOFA/qSOFA and NEWS-2, the associations of the mean score, highest score, and change in score with mortality will be assessed. Conventional statistical tools and supervised machine learning algorithms will be used to identify predictors of ICU mortality.•This study aims to validate the performance of existing ICU PSS in predicting ICU mortality and LOS among West Africans, and to identify their predictors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.